Elizabeth Berry-Kravis is professor of child neurology at Rush University Medical Center in Chicago.
Elizabeth Berry-Kravis
Professor
Rush University Medical Center
From this contributor
Analysis offers new hope for failed fragile X drug
Eye tracking shows that mavoglurant, a once-abandoned experimental drug for fragile X syndrome, enters the brain and boosts social interest, says Elizabeth Berry-Kravis.
Analysis offers new hope for failed fragile X drug
By
Jessica Wright
26 February 2019 | 6 min read
Questions for Elizabeth Berry-Kravis: Dodging mouse traps
A mouse model of fragile X syndrome lacks a key feature of the condition, prompting researchers to look for other ways to test treatments.
Questions for Elizabeth Berry-Kravis: Dodging mouse traps
By
Jessica Wright
24 May 2016 | 6 min read
Questions for Elizabeth Berry-Kravis: Measuring drug effects
Drugs designed to treat fragile X syndrome have yet to show substantial benefits in people. But rather than abandon them, child neurologist Elizabeth Berry-Kravis suggests a new way to measure their effectiveness.
Questions for Elizabeth Berry-Kravis: Measuring drug effects
By
Nicholette Zeliadt
17 February 2015 | 5 min read
Explore more from The Transmitter
‘Wired for Words: The Neural Architecture of Language,’ an excerpt
In his new book, Hickok provides a detailed overview of the research into the circuits that control speech and language. In this excerpt from Chapter 5, he shares how meeting his colleague David Poeppel led to them developing the theory for bilateral speech perception.
‘Wired for Words: The Neural Architecture of Language,’ an excerpt
In his new book, Hickok provides a detailed overview of the research into the circuits that control speech and language. In this excerpt from Chapter 5, he shares how meeting his colleague David Poeppel led to them developing the theory for bilateral speech perception.
By
Gregory Hickok
2 December 2025 | 8 min read
Plumbing the link between anti-CASPR2 antibodies and autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 1 December.
Plumbing the link between anti-CASPR2 antibodies and autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 1 December.
By
Jill Adams
2 December 2025 | 1 min read
This paper changed my life: Nancy Padilla-Coreano on learning the value of population coding
The 2013 Nature paper by Mattia Rigotti and his colleagues revealed how mixed selectivity neurons—cells that are not selectively tuned to a stimulus—play a key role in cognition.
This paper changed my life: Nancy Padilla-Coreano on learning the value of population coding
The 2013 Nature paper by Mattia Rigotti and his colleagues revealed how mixed selectivity neurons—cells that are not selectively tuned to a stimulus—play a key role in cognition.
By
Nancy Padilla-Coreano
1 December 2025 | 5 min read